Post-Approval Study of the Neuspera Sacral Neuromodulation System
ConditionUrinary Urgency Incontinence
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorNeuspera Medical, Inc.
About this trial
Prospective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System.
Participants in this study received intervention/implanted in Phase I or Phase II of the Neuspera SANS\_UUI (NSM-004) Study.
Eligibility criteria
Qualifiers
Subjects in the SANS-UUI Phase I or Phase II study
Disqualifiers
None
Trial design
Treatments tested in this trial
- Neuspera Implantable Sacral Neuromodulation System
Treatment groups
116 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov